全球寡核苷酸合成市场规模、份额、成长分析，按最终用途（学术研究机构、诊断实验室）、按应用（PCR 引子、PCR 检测和麵板）- 2024-2031 年产业预测

Global Oligonucleotide Synthesis Market Size, Share, Growth Analysis, By End-use(Academic Research Institutes, Diagnostic Laboratories), By Application(PCR Primers, PCR Assays and Panels) - Industry Forecast 2024-2031

出版日期: 2024年04月07日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球寡核苷酸合成市场规模为46.0亿美元，预计将从2023年的51.6亿美元成长到2031年的128.6亿美元，预测期间（2024-2031年）复合年增长率为12.10%。

寡核苷酸合成市场透过提供用于各种目的的客製化和预製寡核苷酸来满足研究人员、科学家和製造商的需求，包括基因合成、PCR、DNA 定序、诊断和治疗。该市场的主要驱动力是在基因研究进步的推动下，对合成生物学和个人化医疗的需求不断增长。此外，癌症和遗传性疾病发生率的增加也促进了市场的成长。然而，寡核苷酸合成市场面临确保品质控制、遵守监管标准以及解决与基因合成相关的伦理问题等挑战。此外，寡核苷酸合成日益复杂以及对专业设备和专业知识的需求为市场参与者带来了重大障碍。儘管有这些挑战，市场仍提供创新机会，包括开发新的合成技术和扩大寡核苷酸的应用领域。此外，对个人化医疗和基因治疗的需求不断增长，为市场扩张创造了途径。总体而言，虽然寡核苷酸合成市场有望持续成长，但它可能会遇到与成本、技术熟练程度、品质保证和监管合规性相关的障碍。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Agilent Technologies, Inc. (US)
BioAutomation Corporation (US)
Biosearch Technologies, Inc. (US)
Biolytic Lab Performance Inc. (Canada)
Eurofins Genomics LLC (US)
General Electric Company (US)
GenScript Biotech Corporation (China)
Integrated DNA Technologies, Inc. (US)
Kaneka Eurogentec SA (Belgium)
LGC Limited (UK)
Merck KGaA (Germany)
Nitto Denko Avecia Inc. (US)
Thermo Fisher Scientific Inc. (US)
TriLink BioTechnologies, LLC (US)
Twist Bioscience Corporation (US)
ATDBio Ltd. (UK)
Axil Scientific Pte Ltd. (Singapore)
Biogen International GmbH (Switzerland)
Biomer Technology LLC (US)
Bio-Synthesis, Inc. (US)

简介目录

Product Code: SQMIG35H2107

Global oligonucleotide synthesis market size was valued at USD 4.60 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 12.86 billion by 2031, at a CAGR of 12.10% during the forecast period (2024-2031).

The oligonucleotide synthesis market serves the needs of researchers, scientists, and manufacturers by offering customized and pre-manufactured oligonucleotides for various purposes, including gene synthesis, PCR, DNA sequencing, diagnostics, and therapeutics. A primary driver of this market is the rising demand for synthetic biology and personalized medicine, fueled by advancements in genetic research. Additionally, the growing incidence of cancer and genetic disorders contributes to the market's growth. However, the oligonucleotide synthesis market encounters challenges such as ensuring quality control, adhering to regulatory standards, and addressing ethical concerns related to gene synthesis. Moreover, the increasing complexity of oligonucleotide synthesis and the requirement for specialized equipment and expertise present significant hurdles for market participants. Despite these challenges, the market offers opportunities for innovation, including the development of new synthesis technologies and expanding the application areas for oligonucleotides. Furthermore, the rising demand for personalized medicine and gene therapy creates avenues for market expansion. Overall, while the oligonucleotide synthesis market is poised for continued growth, it may encounter obstacles related to cost, technical proficiency, quality assurance, and regulatory compliance.

Top-down and bottom-up approaches were used to estimate and validate the size of the global oligonucleotide synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oligonucleotide Synthesis Market Segmental Analysis

The global oligonucleotide synthesis market is segmented based on end-use, application, and region. By end-use, the market is segmented into academic research institutes, diagnostic laboratories, and pharmaceutical - biotechnology companies. By application, the market is segmented into PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), Antisense oligonucleotides, and other applications. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Oligonucleotide Synthesis Market

The global oligonucleotide synthesis market is being propelled by the increasing need for oligonucleotides in drug development and diagnostics. Oligonucleotides such as PCR primers, antisense oligonucleotides, and siRNA are extensively utilized in these fields, contributing to the market's growth.

Restraints in the Global Oligonucleotide Synthesis Market

The oligonucleotide synthesis market faces a notable hurdle due to the high cost associated with the synthesis process. This complexity necessitates specialized equipment and expertise, thereby increasing the manufacturing expenses for oligonucleotides.

Market Trends of the Global Oligonucleotide Synthesis Market

The demand for tailored oligonucleotides has been on the rise, catering to specific applications in fields like research, diagnostics, and therapeutics. This trend is driven by the expanding utilization of oligonucleotides in drug development, genetic testing, and personalized medicine. Integrated DNA Technologies, a prominent supplier of customized oligonucleotides, exemplifies this trend by offering a diverse array of oligonucleotides tailored for various research, diagnostic, and therapeutic purposes.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Oligonucleotide Synthesis Market by End-use

Market Overview
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical Biotechnology Companies

Global Oligonucleotide Synthesis Market by Application

Market Overview
PCR Primers
PCR Assays and Panels
Sequencing
DNA Microarrays
Fluorescence in Situ Hybridization (FISH)
Antisense Oligonucleotides
and Other Applications

Global Oligonucleotide Synthesis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAutomation Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosearch Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biolytic Lab Performance Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Genomics LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
General Electric Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Eurogentec S.A. (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nitto Denko Avecia Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriLink BioTechnologies, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATDBio Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axil Scientific Pte Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen International GmbH (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomer Technology LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Synthesis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments